Search research articles
Contact Us
Filters
Showing results (161-170 of 260) with videos related to
Page
of 26
Sort By:
Pharmacoeconomics
|
November 10, 2001
Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective
S E Sinclair, L Frighetto, P S Loewen, et al.
The Annals of Pharmacotherapy
|
February 1, 1993
Labetalol: response and safety in critically ill hemorrhagic stroke patients
R V Patel, H R Kertland, B E Jahns, et al.
DICP : the Annals of Pharmacotherapy
|
December 1, 1991
Assessing the effects of antihypertensive medication on cerebral blood flow: demonstration in internal carotid artery occlusion
S C Fagan, J R Ewing, S R Levine, et al.
The Annals of Pharmacotherapy
|
January 27, 2004
Tracking trends in secondary stroke prevention strategies
Jody L Carswell, Kemberley A Beard, Michele M Chevrette, et al.
Diabetes
|
December 20, 2014
Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes
Mohammed Abdelsaid, Roshini Prakash, Weiguo Li, et al.
Experimental Neurology
|
March 18, 2004
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection
Susan C Fagan, David J Edwards, Cesar V Borlongan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 2014
Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B
Sahar Soliman, Tauheed Ishrat, Anilkumar Pillai, et al.
Neurological Research
|
February 24, 2004
Single slice method for quantification of hemorrhagic transformation using direct ELISA
Hend M Hilali, Alexis N Simpkins, William D Hill, et al.
Stroke
|
September 6, 2014
Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence
Denise M Boudreau, Gregory F Guzauskas, Er Chen, et al.
Neurochemistry International
|
June 10, 2022
Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke
Abdelrahman Y Fouda, Heba A Ahmed, Bindu Pillai, et al.
Page
of 26
Search research articles
Search
Showing results (161-170 of 260) with videos related to
Sort By:
Page
of 26
Pharmacoeconomics
|
November 10, 2001
Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective
S E Sinclair, L Frighetto, P S Loewen, et al.
The Annals of Pharmacotherapy
|
February 1, 1993
Labetalol: response and safety in critically ill hemorrhagic stroke patients
R V Patel, H R Kertland, B E Jahns, et al.
DICP : the Annals of Pharmacotherapy
|
December 1, 1991
Assessing the effects of antihypertensive medication on cerebral blood flow: demonstration in internal carotid artery occlusion
S C Fagan, J R Ewing, S R Levine, et al.
The Annals of Pharmacotherapy
|
January 27, 2004
Tracking trends in secondary stroke prevention strategies
Jody L Carswell, Kemberley A Beard, Michele M Chevrette, et al.
Diabetes
|
December 20, 2014
Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes
Mohammed Abdelsaid, Roshini Prakash, Weiguo Li, et al.
Experimental Neurology
|
March 18, 2004
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection
Susan C Fagan, David J Edwards, Cesar V Borlongan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 2014
Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: role of vascular endothelial growth factors A and B
Sahar Soliman, Tauheed Ishrat, Anilkumar Pillai, et al.
Neurological Research
|
February 24, 2004
Single slice method for quantification of hemorrhagic transformation using direct ELISA
Hend M Hilali, Alexis N Simpkins, William D Hill, et al.
Stroke
|
September 6, 2014
Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence
Denise M Boudreau, Gregory F Guzauskas, Er Chen, et al.
Neurochemistry International
|
June 10, 2022
Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke
Abdelrahman Y Fouda, Heba A Ahmed, Bindu Pillai, et al.
Page
of 26